Journal article icon

Journal article

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Abstract:

Invariant natural killer T (iNKT) cells are powerful immunomodulatory cells that in mice regulate a variety of immune responses, including acute GVHD (aGVHD). However, their clinical relevance and in particular their role in clinical aGVHD are not known. We studied whether peripheral blood stem cell (PBSC) graft iNKT-cell dose affects on the occurrence of clinically significant grade II-IV aGVHD in patients (n = 57) undergoing sibling, HLA-identical allogeneic HSCT. In multivariate analysis, ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1182/blood-2011-11-389304

Authors


Expand authors...
Leukaemia and Lymphoma Research More from this funder
National Institute of Health Research More from this funder
Publisher:
American Society for Hematology Publisher's website
Journal:
Blood Journal website
Volume:
119
Issue:
21
Pages:
5030-5036
Publication date:
2012-05-01
Acceptance date:
2012-02-16
DOI:
EISSN:
1528-0020
ISSN:
0006-4971
Source identifiers:
508070

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP